,19 An alternative explanation may be that in some individuals, COVID-19-related neuroinflammation restricted glymphatic clearance causing increased aggregation of larger proteins (like NfL or GFAP: width ∼10 nm) but potentially allowing smaller proteins like pTau-181 (5 nm) to pass through unimpeded. The gene discussed is GFAP; the disease is COVID-19.